BACKGROUND: Many trials have tested different strategies to increase colorectal cancer (CRC) screening. Few describe whether participants are representative of the population from which they are recruited. PURPOSE: To determine risk factors related to nonparticipation among patients enrolled in an integrated health plan and not up to date for CRC testing, in a trial to increase screening rates. METHODS:Between July 2008 and October 2009, a total of 15,000 adults aged 50-74 years from 21 clinics in Washington State who were due for CRC screening were contacted. Nonparticipants were defined as English-speaking patients who did not engage in the call or refused participation while still potentially eligible. Log-binomial regression models were used to estimate the relative risk of nonparticipation. Analyses were completed between October 2010 and June 2011. RESULTS:Patients who were nonwhite, had less education, used tobacco, had less continuity of care, and had lower rates of preventive care and cancer screening were more likely to be nonparticipants. Patients reporting never having received any type of CRC testing or screening were also more likely not to participate (62% of nonparticipants vs 46% of participants; adjusted RR=1.58, 95% CI=1.47, 1.70). Reasons for refusal included costs, risks of procedures, and not wanting their medical records reviewed. CONCLUSIONS: Patients eligible for but not participating in the trial were more likely to be from minority socioeconomic and racial groups and had behaviors that can negatively affect cancer outcomes. Additional efforts are needed to recruit patients who need CRC screening the most. TRIAL REGISTRATION: This trial is registered at clinicaltrials.gov NCT 00697047. Copyright Â
RCT Entities:
BACKGROUND: Many trials have tested different strategies to increase colorectal cancer (CRC) screening. Few describe whether participants are representative of the population from which they are recruited. PURPOSE: To determine risk factors related to nonparticipation among patients enrolled in an integrated health plan and not up to date for CRC testing, in a trial to increase screening rates. METHODS: Between July 2008 and October 2009, a total of 15,000 adults aged 50-74 years from 21 clinics in Washington State who were due for CRC screening were contacted. Nonparticipants were defined as English-speaking patients who did not engage in the call or refused participation while still potentially eligible. Log-binomial regression models were used to estimate the relative risk of nonparticipation. Analyses were completed between October 2010 and June 2011. RESULTS:Patients who were nonwhite, had less education, used tobacco, had less continuity of care, and had lower rates of preventive care and cancer screening were more likely to be nonparticipants. Patients reporting never having received any type of CRC testing or screening were also more likely not to participate (62% of nonparticipants vs 46% of participants; adjusted RR=1.58, 95% CI=1.47, 1.70). Reasons for refusal included costs, risks of procedures, and not wanting their medical records reviewed. CONCLUSIONS:Patients eligible for but not participating in the trial were more likely to be from minority socioeconomic and racial groups and had behaviors that can negatively affect cancer outcomes. Additional efforts are needed to recruit patients who need CRC screening the most. TRIAL REGISTRATION: This trial is registered at clinicaltrials.gov NCT 00697047. Copyright Â
Authors: Timothy J Beebe; Nicholas J Talley; Michael Camilleri; Sarah M Jenkins; Kari J Anderson; G Richard Locke Journal: Med Care Date: 2007-10 Impact factor: 2.983
Authors: Jean G Ford; Mollie W Howerton; Gabriel Y Lai; Tiffany L Gary; Shari Bolen; M Chris Gibbons; Jon Tilburt; Charles Baffi; Teerath Peter Tanpitukpongse; Renee F Wilson; Neil R Powe; Eric B Bass Journal: Cancer Date: 2008-01-15 Impact factor: 6.860
Authors: Deborah J del Junco; Sally W Vernon; Sharon P Coan; Jasmin A Tiro; Lori A Bastian; Lara S Savas; Catherine A Perz; David R Lairson; Wen Chan; Cynthia Warrick; Amy McQueen; William Rakowski Journal: J Natl Cancer Inst Date: 2008-02-26 Impact factor: 13.506
Authors: Lois E Lamerato; Pamela M Marcus; Gordon Jacobsen; Christine Cole Johnson Journal: Cancer Epidemiol Biomarkers Prev Date: 2008-04 Impact factor: 4.254
Authors: David Wendler; Raynard Kington; Jennifer Madans; Gretchen Van Wye; Heidi Christ-Schmidt; Laura A Pratt; Otis W Brawley; Cary P Gross; Ezekiel Emanuel Journal: PLoS Med Date: 2005-12-06 Impact factor: 11.069
Authors: Richard T Meenan; Melissa L Anderson; Jessica Chubak; Sally W Vernon; Sharon Fuller; Ching-Yun Wang; Beverly B Green Journal: Am J Prev Med Date: 2015-06 Impact factor: 5.043
Authors: Beverly B Green; Melissa L Anderson; Jessica Chubak; Sharon Fuller; Richard T Meenan; Sally W Vernon Journal: Cancer Date: 2015-10-21 Impact factor: 6.860
Authors: Beverly B Green; Melissa L Anderson; Andrea J Cook; Jessica Chubak; Sharon Fuller; Richard T Meenan; Sally W Vernon Journal: Cancer Date: 2017-07-28 Impact factor: 6.860
Authors: Caitlin C Murphy; Sally W Vernon; Nicole M Haddock; Melissa L Anderson; Jessica Chubak; Beverly B Green Journal: Prev Med Date: 2014-06-15 Impact factor: 4.018
Authors: Beverly B Green; Melissa L Anderson; Jessica Chubak; Laura Mae Baldwin; Leah Tuzzio; Sheryl Catz; Alison Cole; Sally W Vernon Journal: J Am Board Fam Med Date: 2016 Mar-Apr Impact factor: 2.657
Authors: Rafeek A Yusuf; Deevakar Rogith; Shelly R A Hovick; Susan K Peterson; Allison M Burton-Chase; Bryan M Fellman; Yisheng Li; Carolyn McKinney; Elmer V Bernstam; Funda Meric-Bernstam Journal: Cancer Date: 2014-09-10 Impact factor: 6.860